Close  

Red Cross-LT Group molecular lab inaugurated

06:59 PM July 14, 2020
Philippine Red Cross (PRC) chairman Senator Richard Gordon (2nd from left) leads the recent inauguration of PRC’s sixth molecular laboratory located in Batangas City. Donated by LT Group, Inc., the listed holding firm of tycoon Lucio C. Tan, the new lab is capable of conducting 4,000 COVID-19 tests daily using its own automated RNA Extraction and Polymerase Chain Reaction (PCR) machine. Open to the public since July 11, the lab can also detect tuberculosis, cancer, HIV, dengue, malaria, hepatitis and Zika, among others. Joining Sen. Gordon are (L-R): LT Group chief finance officer Jose Gabriel Olives; Atty. Raul Academia of tocacco firm PMFTC; and Asia Brewery vice president Dr. Rocky Rivera.

Philippine Red Cross (PRC) chairman Senator Richard Gordon (2nd from left) leads the recent inauguration of PRC’s sixth molecular laboratory located in Batangas City. Donated by LT Group, Inc., the listed holding firm of tycoon Lucio C. Tan, the new lab is capable of conducting 4,000 COVID-19 tests daily using its own automated RNA Extraction and Polymerase Chain Reaction (PCR) machine. Open to the public since July 11, the lab can also detect tuberculosis, cancer, HIV, dengue, malaria, hepatitis and Zika, among others. Joining Sen. Gordon are (L-R): LT Group chief finance officer Jose Gabriel Olives; Atty. Raul Academia of tocacco firm PMFTC; and Asia Brewery vice president Dr. Rocky Rivera.

ADVERTISEMENT

FEATURED STORIES
Read Next
EDITORS' PICK
MOST READ
Don't miss out on the latest news and information.
View comments

Subscribe to INQUIRER PLUS to get access to The Philippine Daily Inquirer & other 70+ titles, share up to 5 gadgets, listen to the news, download as early as 4am & share articles on social media. Call 896 6000.

TAGS:
For feedback, complaints, or inquiries, contact us.


© Copyright 1997-2020 INQUIRER.net | All Rights Reserved

We use cookies to ensure you get the best experience on our website. By continuing, you are agreeing to our use of cookies. To find out more, please click this link.